Validation of Two Plasma Multimetabolite Signatures for Patients at Risk of or with Suspected Pancreatic Ductal Adenocarcinoma (METAPAC): a Prospective, Multicentre, Investigator-Masked, Enrichment Design, Phase 4 Diagnostic Study.
The lancet Gastroenterology & hepatology(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined